María Jesús
Monte Río
Hospital Universitario de Salamanca
Salamanca, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario de Salamanca (19)
2024
-
Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition
Biochemical Pharmacology, Vol. 228
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
2021
-
Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics
Aging, Vol. 13, Núm. 19, pp. 23416-23434
-
Novel pharmacological options in the treatment of cholangiocarcinoma: Mechanisms of resistance
Cancers, Vol. 13, Núm. 10
2019
-
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Hepatology, Vol. 70, Núm. 4, pp. 1246-1261
2018
-
Dysregulation of autophagy in rat liver with mitochondrial DNA depletion induced by the nucleoside analogue zidovudine
Archives of Toxicology, Vol. 92, Núm. 6, pp. 2109-2118
2015
-
Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy
British Journal of Clinical Pharmacology, Vol. 79, Núm. 2, pp. 316-329
2012
-
Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta
Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283
-
Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs
Current Cancer Drug Targets, Vol. 12, Núm. 4, pp. 402-438
2011
-
A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis
Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225
2010
-
Strategies for overcoming chemotherapy resistance in enterohepatic tumours
Current Molecular Medicine, Vol. 10, Núm. 5, pp. 467-485
2009
-
Hepatobiliary transporters in the pharmacology and toxicology of anticancer drugs
Frontiers in Bioscience, Vol. 14, Núm. 11, pp. 4257-4280
2006
-
Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps
Biochemical Pharmacology, Vol. 72, Núm. 6, pp. 729-738
-
Maternal ethanol consumption during pregnancy enhances bile acid-induced oxidative stress and apoptosis in fetal rat liver
Toxicology, Vol. 225, Núm. 2-3, pp. 183-194
2005
-
Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis
Clinical Science, Vol. 109, Núm. 2, pp. 199-207
-
Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis
Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 2, pp. 751-758
-
Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid
Journal of Hepatology, Vol. 43, Núm. 2, pp. 324-332
-
Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism
Journal of Pharmacology and Experimental Therapeutics, Vol. 315, Núm. 1, pp. 24-35
2002
-
Chronic renal failure-induced changes in serum and urine bile acid profiles
Digestive Diseases and Sciences, Vol. 47, Núm. 11, pp. 2398-2406